Recent studies on antibacterials have focused on the development of an
timycobacterial agents and antibacterial peptides, and on furthering t
he understanding of agents that have been available for several decade
s, including imidazoles, beta-lactams and quinolones. New areas of res
earch include antisense oligonucleotides, antibacterial peptides and a
new class of agents, oxazolidinones.